Immunocore Open menu About us Focusing on breakthrough innovation that benefits patients Home / About us We are a pioneering, clinical-stage T cell receptor biotechnology company working to develop and commercialize a new generation of transformative medicines to address unmet needs in cancer, infection and autoimmune disease. Our initial therapeutic focus is in oncology, where pivotal clinical trials are currently underway for our lead program, tebentafusp (IMCgp100), as a potential treatment for metastatic uveal melanoma, a rare form of eye cancer. We also have a robust pipeline of programs spanning a broad range of cancer indications, as well as infectious and autoimmune diseases. Our science Play VIDEO ImmTAC® molecules in action Our story 2019 Immunocore opens an office in the BioHealth Capital Region of Rockville, Maryland. 2019 Immunocore Board appoints Bahija Jallal as Chief Executive Officer. 2018 Partnership with Genentech to expand existing discovery collaboration to co-develop Immunocore's therapeutic candidate IMC-C103C. Our vision At Immunocore, we believe we are TCR pioneers with a passion to transform patients' lives and a goal to deliver new medicines. We will implement this bold vision by following our values. Our values IN THIS SECTION Management team Board of Directors Partners Immunocore About us Our science Our therapy areas For patients Investors/Media Careers Contact us Privacy and Social Media Guidelines Cookies Payments and Disclosures Clinical trials Gender Pay Report ©2021 Immunocore, Ltd. All rights reserved. ImmTAC, ImmTAV, ImmTAB, ImmTAAI and ImmTAX are all registered trademarks of Immunocore, Ltd To offer you a better experience, this site uses cookies, including those of third parties. To find out more and manage your preferences, consult the Cookie notice I Accept

Immunocore Open menu Board of Directors Guiding our bold vision and strategy Home / About us / Board of Directors Professor Sir John Bell CHAIRMAN Read profile Dr. Bahija Jallal CHIEF EXECUTIVE OFFICER Read profile Mr. Travis Coy NON-EXECUTIVE Read profile Roy S. Herbst, MD, PhD NON-EXECUTIVE Read profile Mr. Rob Perez NON-EXECUTIVE Read profile Ms. Kristine Peterson NON-EXECUTIVE Read profile IN THIS SECTION About us Management team Partners Immunocore About us Our science Our therapy areas For patients Investors/Media Careers Contact us Privacy and Social Media Guidelines Cookies Payments and Disclosures Clinical trials Gender Pay Report ©2021 Immunocore, Ltd. All rights reserved. ImmTAC, ImmTAV, ImmTAB, ImmTAAI and ImmTAX are all registered trademarks of Immunocore, Ltd To offer you a better experience, this site uses cookies, including those of third parties. To find out more and manage your preferences, consult the Cookie notice I Accept